EPISODE · Feb 25, 2022 · 46 MIN
The Role of Biomarkers in HR-Positive/HER2-Negative Early Breast Cancer: From Clinical Analysis to Clinical Decisions
from Keeping Current CME
Watch this 4-part discussion with expert pathologists and oncologists on the latest strategies for biomarker testing and treatment planning. Credit available for this activity expires: 2/24/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/968999?src=mkm_podcast_addon_968999
Embed this episode
Ready to play
The Role of Biomarkers in HR-Positive/HER2-Negative Early Breast Cancer: From Clinical Analysis to Clinical Decisions
0:00
46:25
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Keeping Current CME?
This episode is 46 minutes long.
When was this Keeping Current CME episode published?
This episode was published on February 25, 2022.
Can I download this Keeping Current CME episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!